Article Details

New two-year data show Roche's Evrysdi (risdiplam) continues to demonstrate improvement or ...

Retrieved on: 2021-03-16 06:00:00

Tags for this article:

Click the tags to see associated articles and topics

New two-year data show Roche's Evrysdi (risdiplam) continues to demonstrate improvement or .... View article details on hiswai:

Excerpt

Basel, 16 March 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced new exploratory 2-year longer-term data from Part 2 of SUNFISH, ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up